| Rank | Brands | Current Manufacturer | Total Sales ($000) (2010) | % change 2009 |
| 1 | Nexium | AstraZeneca Pharmaceuticals | 5,276,153 | 4.90% |
| 2 | Lipitor | Pfizer Inc | 5,272,576 | -2.30% |
| 3 | Plavix | Bristol-Myers Squibb Company | 4,675,483 | 10.20% |
| 4 | Advair Diskus | GlaxoSmithKline | 3,655,206 | -1.00% |
| 5 | OxyContin | Purdue Pharma LP | 3,554,751 | 13.10% |
| 6 | Abilify | Bristol-Myers Squibb Company | 3,514,265 | 12.70% |
| 7 | Singulair | Merck & Co., Inc. | 3,324,909 | 8.90% |
| 8 | Seroquel | AstraZeneca Pharmaceuticals | 3,222,055 | 2.40% |
| 9 | Crestor | AstraZeneca Pharmaceuticals | 2,922,687 | 27.00% |
| 10 | Cymbalta | Eli Lilly and Company | 2,638,536 | 7.60% |
| 11 | Actos | Takeda Pharmaceuticals North America, Inc | 2,631,930 | 4.20% |
| 12 | Lexapro | Forest Pharmaceuticals, Inc | 2,483,391 | 4.60% |
| 13 | Zyprexa | Eli Lilly and Company | 2,036,092 | 7.70% |
| 14 | Spiriva | Boehringer Ingelheim Pharmaceuticals, Inc | 1,593,593 | 19.30% |
| 15 | Lantus | Sanofi-Aventis | 1,525,697 | 0.30% |
| 16 | Aricept | Eisai Corporation | 1,522,517 | 13.30% |
| 17 | Lyrica | Pfizer Inc | 1,478,158 | -0.10% |
| 18 | Diovan | Novartis Corporation | 1,443,539 | 7.00% |
| 19 | Effexor XR | Wyeth | 1,431,042 | -40.10% |
| 20 | Concerta | Ortho-McNeil-Janssen Pharmaceuticals, Inc. | 1,407,962 | 16.90% |
| 21 | Levaquin | Janssen Pharmaceuticals, Inc | 1,355,350 | -0.60% |
| 22 | Celebrex | Pfizer Inc | 1,349,833 | -6.90% |
| 23 | Diovan HCT | Novartis Corporation | 1,314,507 | 3.70% |
| 24 | Januvia | Merck & Co., Inc. | 1,294,408 | 13.00% |
| 25 | Suboxone | Reckitt Benckiser Pharmaceuticals Inc. | 1,164,872 | 26.60% |
| 26 | NovoLog | Novo Nordisk Inc. | 1,101,447 | 20.60% |
| 27 | Viagra | Pfizer Inc | 1,028,769 | 5.50% |
| 28 | Atripla | Gilead Sciences, Inc. | 1,028,753 | -6.50% |
| 29 | Tricor | Abbott Laboratories | 1,015,682 | -17.20% |
| 30 | Provigil | Cephalon, Inc. | 999,975 | 6.70% |
| 31 | Zetia | Schering-Plough | 985,823 | -4.30% |
| 32 | Geodon oral | Pfizer Inc | 959,057 | 8.70% |
| 33 | Vytorin | Merck & Co., Inc. | 953,625 | -16.30% |
| 34 | Ambien CR | Sanofi-Aventis | 951,108 | -2.50% |
| 35 | Lunesta | Sepracor Inc. | 948,621 | 17.60% |
| 36 | Lidoderm | Endo Pharmaceuticals | 934,418 | -1.10% |
| 37 | Lantus SoloSTAR | Sanofi-Aventis | 933,589 | 50.50% |
| 38 | Vyvanse | Shire US Inc | 931,421 | 40.90% |
| 39 | Aciphex | Eisai Corporation | 915,796 | -8.80% |
| 40 | Nasonex | Schering-Plough | 886,446 | -1.90% |
| 41 | Lovenox | Sanofi-Aventis | 867,240 | -20.40% |
| 42 | Adderall XR | Shire US Inc | 837,448 | -27.00% |
| 43 | ProAir HFA | Teva Pharmaceuticals | 818,903 | -12.60% |
| 44 | Truvada | Gilead Sciences, Inc. | 813,944 | -8.50% |
| 45 | Niaspan | Abbott Laboratories | 793,882 | 11.00% |
| 46 | Humalog | Eli Lilly and Company | 783,294 | 3.20% |
| 47 | Cialis | Eli Lilly and Company | 756,576 | 15.90% |
| 48 | Namenda | Forest Pharmaceuticals, Inc | 744,296 | 10.90% |
| 49 | Symbicort | AstraZeneca Pharmaceuticals | 707,468 | 47.40% |
| 50 | Flovent HFA | GlaxoSmithKline | 704,631 | 13.20% |
| 51 | Seroquel XR | AstraZeneca Pharmaceuticals | 695,560 | 92.10% |
| 52 | Combivent | Boehringer Ingelheim Pharmaceuticals, Inc | 693,068 | 14.30% |
| 53 | Lovaza | GlaxoSmithKline | 682,384 | 15.50% |
| 54 | Solodyn | Medicis Pharmaceutical Corporation | 673,427 | 40.70% |
| 55 | Detrol LA | Pfizer Inc | 620,231 | -13.60% |
| 56 | AndroGel | Abbott Laboratories | 593,780 | 10.10% |
| 57 | Benicar | Daiichi Sankyo | 567,636 | 10.00% |
| 58 | Levemir | Novo Nordisk Inc. | 567,341 | 41.10% |
| 59 | Enbrel | Amgen Inc. | 546,814 | -15.80% |
| 60 | Valtrex | GlaxoSmithKline | 533,961 | -69.90% |
| 61 | Benicar HCT | Daiichi Sankyo | 526,177 | -3.10% |
| 62 | Gleevec | Novartis Corporation | 517,967 | -3.70% |
| 63 | Humira Pen | Abbott Laboratories | 514,735 | 10.10% |
| 64 | Synthroid | Abbott Laboratories | 506,859 | 2.50% |
| 65 | Xalatan | Pfizer Inc | 502,227 | 9.10% |
| 66 | Premarin tabs | Wyeth | 497,757 | -6.50% |
| 67 | Strattera | Eli Lilly and Company | 496,960 | -3.90% |
| 68 | Ventolin HFA | GlaxoSmithKline | 496,659 | 65.40% |
| 69 | Flomax | Boehringer Ingelheim Pharmaceuticals, Inc | 486,106 | -68.90% |
| 70 | Loestrin 24 Fe | Warner Chilcott | 483,754 | 82.30% |
| 71 | Protonix | Wyeth | 481,429 | 3.50% |
| 72 | Boniva | Roche Pharmaceuticals | 480,470 | -5.30% |
| 73 | Restasis | Allergan, Inc | 480,414 | 19.00% |
| 74 | Femara | Novartis Corporation | 477,256 | 12.70% |
| 75 | Enbrel Sureclick | Amgen Inc. | 474,602 | 2.60% |
| 76 | NovoLog Mix 70/30 | Novo Nordisk Inc. | 470,786 | 16.80% |
| 77 | Evista | Eli Lilly and Company | 469,013 | 0.30% |
| 78 | Byetta | Amylin Pharmaceuticals, Inc. | 459,454 | -17.80% |
| 79 | Janumet | Merck & Co., Inc. | 459,068 | 22.70% |
| 80 | Asacol | Procter & Gamble | 450,645 | -8.30% |
| 81 | Avodart | GlaxoSmithKline | 441,486 | 5.50% |
| 82 | Vesicare | Astellas Pharma US | 440,862 | 15.30% |
| 83 | Trilipix | Abbott Laboratories | 428,978 | 104.50% |
| 84 | Copaxone | Sanofi-Aventis | 421,758 | 1.30% |
| 85 | Focalin XR | Novartis Corporation | 416,245 | 18.60% |
| 86 | Reyataz | Bristol-Myers Squibb Company | 412,293 | -20.90% |
| 87 | Pristiq | Wyeth | 411,715 | 58.40% |
| 88 | Arimidex | AstraZeneca Pharmaceuticals | 403,891 | -37.50% |
| 89 | Chantix | Pfizer Inc | 394,944 | -14.30% |
| 90 | Sensipar | Amgen Inc. | 382,232 | -0.50% |
| 91 | Avapro | Bristol-Myers Squibb Company | 369,596 | -6.20% |
| 92 | Opana ER | Endo Pharmaceuticals | 366,417 | 52.50% |
| 93 | Yaz | Bayer Healthcare Pharmaceuticals | 361,958 | -49.10% |
| 94 | Doryx | Pfizer Inc | 361,662 | 35.70% |
| 95 | Actoplus Met | Takeda Pharmaceuticals North America, Inc | 359,790 | 4.70% |
| 96 | Humira | Abbott Laboratories | 358,012 | -12.50% |
| 97 | Avelox | Bayer Healthcare Pharmaceuticals | 353,130 | -8.40% |
| 98 | NuvaRing | Merck & Co., Inc. | 349,014 | 11.00% |
| 99 | Renvela | Genzyme Corporation | 333,987 | 111.50% |
| 100 | Ortho Tri-Cyclen Lo | Ortho-McNeil-Janssen Pharmaceuticals, Inc. | 331,730 | 33.90% |
| 101 | Lamictal | GlaxoSmithKline | 326,331 | -35.20% |
| 102 | Avalide | Bristol-Myers Squibb Company | 324,571 | -6.40% |
| 103 | Xopenex | Sepracor Inc. | 316,162 | -13.00% |
| 104 | Actonel | Procter & Gamble | 313,904 | -29.00% |
| 105 | Dexilant/Kapidex | 313,386 | 254.80% | |
| 106 | Lotrel | Novartis Corporation | 306,010 | -6.80% |
| 107 | Invega | Janssen Pharmaceuticals, Inc | 304,182 | 5.10% |
| 108 | Welchol | Daiichi Sankyo | 303,392 | 19.70% |
| 109 | Avonex | Biogen Idec | 303,147 | 0.20% |
| 110 | Topamax | Janssen Pharmaceuticals, Inc | 287,186 | -70.50% |
| 111 | Norvir | Abbott Laboratories | 287,102 | -10.00% |
| 112 | Entocort EC | AstraZeneca Pharmaceuticals | 282,547 | 38.60% |
| 113 | Aggrenox | Boehringer Ingelheim Pharmaceuticals, Inc | 277,144 | 6.50% |
| 114 | Travatan Z | Alcon Laboratories, Inc. | 273,598 | 44.10% |
| 115 | Isentress | Merck & Co., Inc. | 272,132 | -9.80% |
| 116 | Avandia | GlaxoSmithKline | 269,213 | -33.80% |
| 117 | Prevacid SoluTab | Takeda Pharmaceuticals North America, Inc | 268,284 | -1.40% |
| 118 | Exforge | Novartis Corporation | 267,771 | 16.60% |
| 119 | Cozaar | Merck & Co., Inc. | 267,081 | -62.40% |
| 120 | Lumigan | Allergan, Inc | 267,047 | 7.00% |
| 121 | Caduet | Pfizer Inc | 266,967 | -18.60% |
| 122 | Actonel 150 | Procter & Gamble | 264,858 | 26.20% |
| 123 | Risperdal Consta | Janssen Pharmaceuticals, Inc | 262,054 | -8.20% |
| 124 | Prograf | Astellas Pharma US | 260,885 | -56.20% |
| 125 | Ciprodex otic | Alcon Laboratories, Inc. | 254,888 | 13.80% |
| 126 | Vigamox | Alcon Laboratories, Inc. | 252,864 | 11.30% |
| 127 | Kadian | Actavis | 251,858 | -0.80% |
| 128 | Coreg CR | GlaxoSmithKline | 251,440 | -1.60% |
| 129 | Levitra | Bayer Healthcare Pharmaceuticals | 242,446 | -5.90% |
| 130 | Maxalt | Merck & Co., Inc. | 242,237 | 0.50% |
| 131 | Keppra | UCB Inc. | 241,737 | -33.00% |
| 132 | Prevacid | Takeda Pharmaceuticals North America, Inc | 241,374 | -90.60% |
| 133 | Micardis | Boehringer Ingelheim Pharmaceuticals, Inc | 238,335 | 23.90% |
| 134 | Bystolic | Forest Pharmaceuticals, Inc | 231,449 | 72.20% |
| 135 | Prezista | Centocor Ortho Biotech, Inc | 230,406 | 13.80% |
| 136 | Exelon Patch | Novartis Corporation | 229,601 | 38.20% |
| 137 | Nuvigil | Cephalon, Inc. | 223,885 | 239.60% |
| 138 | Zyvox | Pfizer Inc | 222,554 | -7.50% |
| 139 | Lialda | Shire US Inc | 222,201 | 29.30% |
| 140 | Epzicom | GlaxoSmithKline | 221,406 | -17.00% |
| 141 | Enablex | Warner Chilcott | 220,478 | 11.00% |
| 142 | Forteo | Eli Lilly and Company | 219,387 | -25.10% |
| 143 | Viread | Gilead Sciences, Inc. | 216,264 | -6.20% |
| 144 | Kaletra | Abbott Laboratories | 212,723 | -32.90% |
| 145 | Micardis HCT | Abbott Laboratories | 211,575 | 10.40% |
| 146 | Maxalt MLT | Merck & Co., Inc. | 211,230 | -1.10% |
| 147 | Humalog Mix 75/25 Pen | Eli Lilly and Company | 211,021 | -6.90% |
| 148 | Xeloda | Roche Pharmaceuticals | 209,499 | -11.70% |
| 149 | Asmanex | Schering-Plough | 208,839 | 3.80% |
| 150 | Hyzaar | Merck & Co., Inc. | 207,471 | -62.30% |
| 151 | Fentora | Cephalon, Inc. | 207,376 | 11.20% |
| 152 | Pulmicort Respules | AstraZeneca Pharmaceuticals | 205,218 | -68.00% |
| 153 | Ranexa | Gilead Sciences, Inc. | 200,622 | 41.50% |
| 154 | RenaGel | Genzyme Corporation | 199,275 | -48.20% |
| 155 | Prempro | Wyeth | 198,132 | 22.20% |
| 156 | Relpax | Pfizer Inc | 197,341 | -3.40% |
| 157 | Patanol | Alcon Laboratories, Inc. | 196,500 | 2.60% |
| 158 | Amitiza | Takeda Pharmaceuticals North America, Inc | 195,132 | 1.40% |
| 159 | Duragesic | 194,599 | -14.50% | |
| 160 | Vancocin HCl | Eli Lilly and Company | 192,066 | 23.40% |
| 161 | Nasacort AQ | Sanofi-Aventis | 192,035 | -19.00% |
| 162 | Proventil HFA | Schering-Plough | 191,839 | -26.50% |
| 163 | Advair HFA | GlaxoSmithKline | 191,245 | 26.40% |
| 164 | Valcyte | Roche Pharmaceuticals | 191,160 | -0.90% |
| 165 | Wellbutrin XL | Valeant Pharmaceuticals International | 189,026 | -21.20% |
| 166 | Oracea | Galderma Laboratories | 187,182 | 67.90% |
| 167 | Vivelle-DOT | Novartis Corporation | 185,860 | 12.40% |
| 168 | Uroxatral | Sanofi-Aventis | 185,624 | 6.20% |
| 169 | Zovirax topical | GlaxoSmithKline | 184,377 | 2.60% |
| 170 | Epipen | 182,785 | 20.80% | |
| 171 | Creon | Solvay Pharmaceuticals, Inc. | 181,303 | 358.60% |
| 172 | Azor | 179,647 | 33.00% | |
| 173 | Pentasa | Sanofi-Aventis | 178,068 | 4.50% |
| 174 | Procrit | Centocor Ortho Biotech, Inc | 174,622 | -25.90% |
| 175 | Pataday | Alcon Laboratories, Inc. | 173,553 | 25.50% |
| 176 | Differin | Galderma Laboratories | 171,454 | -24.80% |
| 177 | Premarin vaginal | Wyeth | 170,860 | 3.50% |
| 178 | Zyprexa Zydis | Eli Lilly and Company | 169,714 | 6.70% |
| 179 | Tussionex | Sanofi-Aventis | 169,611 | -29.80% |
| 180 | Victoza | Novo Nordisk Inc. | 168,943 | 0.00% |
| 181 | Humalog KwikPen | Eli Lilly and Company | 168,270 | 79.60% |
| 182 | Arixtra | GlaxoSmithKline | 165,530 | 19.90% |
| 183 | Qvar | Janssen Pharmaceuticals, Inc | 163,697 | 41.10% |
| 184 | Combivir | GlaxoSmithKline | 163,406 | -27.80% |
| 185 | Testim | 163,015 | 12.20% | |
| 186 | Tarceva | Genentech, Inc | 160,591 | -38.20% |
| 187 | Xyzal | Sanofi-Aventis | 160,237 | -15.60% |
| 188 | Elmiron | Ortho-McNeil-Janssen Pharmaceuticals, Inc. | 158,274 | 4.30% |
| 189 | Propecia | Merck & Co., Inc. | 157,892 | -5.70% |
| 190 | CellCept | Roche Pharmaceuticals | 157,743 | -68.30% |
| 191 | Skelaxin | Elan Corporation | 156,372 | -67.70% |
| 192 | Betaseron | Bayer Healthcare Pharmaceuticals | 155,952 | -6.80% |
| 193 | Temodar | Schering-Plough | 154,466 | -14.90% |
| 194 | Flector | Actavis | 153,814 | 0.20% |
| 195 | Pegasys | Roche Pharmaceuticals | 153,101 | -8.40% |
| 196 | Prandin | Novo Nordisk Inc. | 151,678 | -5.90% |
| 197 | Veramyst | GlaxoSmithKline | 150,582 | -7.80% |
| 198 | Intuniv | Shire US Inc | 150,346 | NA |
| 199 | Clobex | Galderma Laboratories | 150,230 | 20.60% |
| 200 | Humulin N | Eli Lilly and Company | 149,945 | 4.40% |
Source: Verispan, VONA